Suscetibilidade in vitro de Candida rugosa frente a antifúngicos e óleos essenciais
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Tipo de documento: | Dissertação |
Idioma: | por |
Título da fonte: | Manancial - Repositório Digital da UFSM |
dARK ID: | ark:/26339/001300000mfxd |
Texto Completo: | http://repositorio.ufsm.br/handle/1/20424 |
Resumo: | The isolation of Candida non-albicans species has increased, as well as the resistance of these yeasts to the existing antifungal. Candida rugosa (Diutina rugosa) has been considered an emerging pathogen and affects humans and animals. Assessment of antifungal susceptibility is one way of monitoring resistance and predicting appropriate therapies. In this context, the present study evaluated the sensitivity of C. rugosa isolates against fluconazole, voriconazole, ketoconazole, itraconazole, amphotericin B, nystatin, terbinafine, flucytosine, caspofungin, micafungin and anidulafungin. In addition, as a way of seeking alternatives to conventional treatments, the in vitro antifungal activity of the essential oils obtained from Origanum vulgare (oregano), Cinnamomum cassia (cassia), Rosmarinus officinalis (rosemary), Ocimum basilicum (basil), Piper nigrum (black pepper) and the compounds carvracol, thimol and cinnamaldehyde against C. rugosa. Fifteen C. rugosa strains isolated from animals (nine dogs, three cows, one equine, one coati, one hawk) were used. The broth microdilution methodology standardized by Clinical and Laboratory Standards Institute (CLSI) document M27-A3 was used to determine the Minimum Inhibitory Concentration (MIC) of the tested agents. The results showed MIC capable of inhibiting 90% of the tested strains of: 0.125 μg/mL for ketoconazole and voriconazole; 0.25 μg/mL for micafungin; 0.5 μg/mL for anidulafungin; 1 μg/mL for caspofungin; 2 μg/mL for itraconazole, flucytosine and amphotericin B; 8 μg/mL for fluconazole and 16 μg/mL for nystatin. Terbinafine was not able to inhibit the yeast growth. The compounds carvacrol, thimol and cinnamaldehyde and the essential oils of oregano, cassia and basil presented MIC ranged from 40 μg/mL to 320 μg/mL. Moreover, the essential oils of black pepper and rosemary were tested but did not present activity in the concentration used. In conclusion, the present work demonstrated the susceptibility profile of a small collection of C. rugosa isolated from animals to eleven commercial antifungals; however, it is necessary to establish species-specific breakpoints to better characterize the susceptibility. It was also shown that the oils of oregano, cinnamon cassia, basil and the compounds carvacrol, thymol and cinnamaldehyde are possible alternatives of treatment and deserve in vivo evaluation to confirm their activity against C. rugosa infections. |
id |
UFSM_aef1b20c06fc7cefc2ae20535d73aeb9 |
---|---|
oai_identifier_str |
oai:repositorio.ufsm.br:1/20424 |
network_acronym_str |
UFSM |
network_name_str |
Manancial - Repositório Digital da UFSM |
repository_id_str |
|
spelling |
Suscetibilidade in vitro de Candida rugosa frente a antifúngicos e óleos essenciaisIn vitro susceptibility of Candida rugosa against antifungals and essential oilsCandida rugosaDiutina rugosaSuscetibilidadeAntifúngicosÓleos essenciaisSusceptibilityAntifungalsEssential oilsCNPQ::CIENCIAS DA SAUDE::FARMACIAThe isolation of Candida non-albicans species has increased, as well as the resistance of these yeasts to the existing antifungal. Candida rugosa (Diutina rugosa) has been considered an emerging pathogen and affects humans and animals. Assessment of antifungal susceptibility is one way of monitoring resistance and predicting appropriate therapies. In this context, the present study evaluated the sensitivity of C. rugosa isolates against fluconazole, voriconazole, ketoconazole, itraconazole, amphotericin B, nystatin, terbinafine, flucytosine, caspofungin, micafungin and anidulafungin. In addition, as a way of seeking alternatives to conventional treatments, the in vitro antifungal activity of the essential oils obtained from Origanum vulgare (oregano), Cinnamomum cassia (cassia), Rosmarinus officinalis (rosemary), Ocimum basilicum (basil), Piper nigrum (black pepper) and the compounds carvracol, thimol and cinnamaldehyde against C. rugosa. Fifteen C. rugosa strains isolated from animals (nine dogs, three cows, one equine, one coati, one hawk) were used. The broth microdilution methodology standardized by Clinical and Laboratory Standards Institute (CLSI) document M27-A3 was used to determine the Minimum Inhibitory Concentration (MIC) of the tested agents. The results showed MIC capable of inhibiting 90% of the tested strains of: 0.125 μg/mL for ketoconazole and voriconazole; 0.25 μg/mL for micafungin; 0.5 μg/mL for anidulafungin; 1 μg/mL for caspofungin; 2 μg/mL for itraconazole, flucytosine and amphotericin B; 8 μg/mL for fluconazole and 16 μg/mL for nystatin. Terbinafine was not able to inhibit the yeast growth. The compounds carvacrol, thimol and cinnamaldehyde and the essential oils of oregano, cassia and basil presented MIC ranged from 40 μg/mL to 320 μg/mL. Moreover, the essential oils of black pepper and rosemary were tested but did not present activity in the concentration used. In conclusion, the present work demonstrated the susceptibility profile of a small collection of C. rugosa isolated from animals to eleven commercial antifungals; however, it is necessary to establish species-specific breakpoints to better characterize the susceptibility. It was also shown that the oils of oregano, cinnamon cassia, basil and the compounds carvacrol, thymol and cinnamaldehyde are possible alternatives of treatment and deserve in vivo evaluation to confirm their activity against C. rugosa infections.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESO isolamento de espécies de Candida não-albicans tem aumentado, assim como a resistência dessas leveduras aos antifúngicos existentes. Candida rugosa (Diutina rugosa) tem sido considerado patógeno emergente e acomete humanos e animais. A avaliação da suscetibilidade aos antifúngicos é uma forma de monitorar a resistência e optar por terapias com melhor resposta. Nesse intuito, o presente estudo, avaliou a sensibilidade de isolados de C. rugosa frente aos fármacos fluconazol, voriconazol, cetoconazol, itraconazol, anfotericina B, nistatina, terbinafina, flucitosina, caspofungina, micafungina e anidulafungina. Além disso, como forma de buscar alternativas aos tratamentos convencionais, avaliou-se a atividade antifúngica in vitro dos óleos essenciais obtidos de Origanum vulgare (orégano), Cinnamomum cassia (canela cassia), Rosmarinus officinalis (alecrim), Ocimum basilicum (manjericão), Piper nigrum (pimenta petra) e os compostos carvracol, timol e cinamaldeído frente a C. rugosa. Foram utilizadas quinze cepas de C. rugosa isoladas a partir de animais (nove cães, três bovinos, um equino, um quati e um gavião). Empregou-se a metodologia de microdiluição em caldo padronizada pelo documento M27- A3 do Clinical and Laboratory Standards Institute (CLSI), através da qual determinou-se Concentração Inibitória Mínima (CIM) dos agentes testados. Os resultados demonstraram CIM capaz de inibir 90% das cepas testadas de: 0,125 μg/mL para cetoconazol e voriconazol; 0,25 μg/mL para micafungina; 0,5 μg/mL para anidulafungina; 1 μg/mL para caspofungina; 2 μg/mL para itraconazol, flucitosina e anfotericina B; 8 μg/mL para fluconazol e 16 μg/mL para nistatina. Terbinafina não foi capaz de inibir as cepas de C. rugosa testadas. Os compostos majoritários e os óleos essenciais de orégano, canela cássia e manjericão apresentaram CIM variando de 40 μg/mL a 320 μg/mL. Os óleos de alecrim e pimenta preta, entretanto, não apresentaram atividade inibitória nas concentrações testadas. Em conclusão, o presente trabalho demonstrou o perfil de suscetibilidade de uma pequena coleção de C. rugosa isoladas de animais a onze antifúngicos comerciais; ressalta-se, porém a necessidade de estabelecimento de breakpoints espécie-específicos para melhor caracterização da suscetibilidade. Mostrou-se também que os óleos de orégano, canela cássia, manjericão e os compostos carvacrol, timol e cinamaldeído apresentam-se como possíveis alternativas de tratamento e merecem avaliação in vivo para confirmação de sua atividade frente a infecções por C. rugosa.Universidade Federal de Santa MariaBrasilFarmacologiaUFSMPrograma de Pós-Graduação em FarmacologiaCentro de Ciências da SaúdeSanturio, Janio Moraishttp://lattes.cnpq.br/6316012260769979Loreto, Érico Silva dehttp://lattes.cnpq.br/5475233864057995Alves, Sydney Hartzhttp://lattes.cnpq.br/0330782478769631Ludwig, Aline2021-03-15T10:32:23Z2021-03-15T10:32:23Z2018-03-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/20424ark:/26339/001300000mfxdporAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2021-03-16T06:01:28Zoai:repositorio.ufsm.br:1/20424Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2024-07-29T10:45:12.313502Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false |
dc.title.none.fl_str_mv |
Suscetibilidade in vitro de Candida rugosa frente a antifúngicos e óleos essenciais In vitro susceptibility of Candida rugosa against antifungals and essential oils |
title |
Suscetibilidade in vitro de Candida rugosa frente a antifúngicos e óleos essenciais |
spellingShingle |
Suscetibilidade in vitro de Candida rugosa frente a antifúngicos e óleos essenciais Ludwig, Aline Candida rugosa Diutina rugosa Suscetibilidade Antifúngicos Óleos essenciais Susceptibility Antifungals Essential oils CNPQ::CIENCIAS DA SAUDE::FARMACIA |
title_short |
Suscetibilidade in vitro de Candida rugosa frente a antifúngicos e óleos essenciais |
title_full |
Suscetibilidade in vitro de Candida rugosa frente a antifúngicos e óleos essenciais |
title_fullStr |
Suscetibilidade in vitro de Candida rugosa frente a antifúngicos e óleos essenciais |
title_full_unstemmed |
Suscetibilidade in vitro de Candida rugosa frente a antifúngicos e óleos essenciais |
title_sort |
Suscetibilidade in vitro de Candida rugosa frente a antifúngicos e óleos essenciais |
author |
Ludwig, Aline |
author_facet |
Ludwig, Aline |
author_role |
author |
dc.contributor.none.fl_str_mv |
Santurio, Janio Morais http://lattes.cnpq.br/6316012260769979 Loreto, Érico Silva de http://lattes.cnpq.br/5475233864057995 Alves, Sydney Hartz http://lattes.cnpq.br/0330782478769631 |
dc.contributor.author.fl_str_mv |
Ludwig, Aline |
dc.subject.por.fl_str_mv |
Candida rugosa Diutina rugosa Suscetibilidade Antifúngicos Óleos essenciais Susceptibility Antifungals Essential oils CNPQ::CIENCIAS DA SAUDE::FARMACIA |
topic |
Candida rugosa Diutina rugosa Suscetibilidade Antifúngicos Óleos essenciais Susceptibility Antifungals Essential oils CNPQ::CIENCIAS DA SAUDE::FARMACIA |
description |
The isolation of Candida non-albicans species has increased, as well as the resistance of these yeasts to the existing antifungal. Candida rugosa (Diutina rugosa) has been considered an emerging pathogen and affects humans and animals. Assessment of antifungal susceptibility is one way of monitoring resistance and predicting appropriate therapies. In this context, the present study evaluated the sensitivity of C. rugosa isolates against fluconazole, voriconazole, ketoconazole, itraconazole, amphotericin B, nystatin, terbinafine, flucytosine, caspofungin, micafungin and anidulafungin. In addition, as a way of seeking alternatives to conventional treatments, the in vitro antifungal activity of the essential oils obtained from Origanum vulgare (oregano), Cinnamomum cassia (cassia), Rosmarinus officinalis (rosemary), Ocimum basilicum (basil), Piper nigrum (black pepper) and the compounds carvracol, thimol and cinnamaldehyde against C. rugosa. Fifteen C. rugosa strains isolated from animals (nine dogs, three cows, one equine, one coati, one hawk) were used. The broth microdilution methodology standardized by Clinical and Laboratory Standards Institute (CLSI) document M27-A3 was used to determine the Minimum Inhibitory Concentration (MIC) of the tested agents. The results showed MIC capable of inhibiting 90% of the tested strains of: 0.125 μg/mL for ketoconazole and voriconazole; 0.25 μg/mL for micafungin; 0.5 μg/mL for anidulafungin; 1 μg/mL for caspofungin; 2 μg/mL for itraconazole, flucytosine and amphotericin B; 8 μg/mL for fluconazole and 16 μg/mL for nystatin. Terbinafine was not able to inhibit the yeast growth. The compounds carvacrol, thimol and cinnamaldehyde and the essential oils of oregano, cassia and basil presented MIC ranged from 40 μg/mL to 320 μg/mL. Moreover, the essential oils of black pepper and rosemary were tested but did not present activity in the concentration used. In conclusion, the present work demonstrated the susceptibility profile of a small collection of C. rugosa isolated from animals to eleven commercial antifungals; however, it is necessary to establish species-specific breakpoints to better characterize the susceptibility. It was also shown that the oils of oregano, cinnamon cassia, basil and the compounds carvacrol, thymol and cinnamaldehyde are possible alternatives of treatment and deserve in vivo evaluation to confirm their activity against C. rugosa infections. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-03-01 2021-03-15T10:32:23Z 2021-03-15T10:32:23Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://repositorio.ufsm.br/handle/1/20424 |
dc.identifier.dark.fl_str_mv |
ark:/26339/001300000mfxd |
url |
http://repositorio.ufsm.br/handle/1/20424 |
identifier_str_mv |
ark:/26339/001300000mfxd |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Santa Maria Brasil Farmacologia UFSM Programa de Pós-Graduação em Farmacologia Centro de Ciências da Saúde |
publisher.none.fl_str_mv |
Universidade Federal de Santa Maria Brasil Farmacologia UFSM Programa de Pós-Graduação em Farmacologia Centro de Ciências da Saúde |
dc.source.none.fl_str_mv |
reponame:Manancial - Repositório Digital da UFSM instname:Universidade Federal de Santa Maria (UFSM) instacron:UFSM |
instname_str |
Universidade Federal de Santa Maria (UFSM) |
instacron_str |
UFSM |
institution |
UFSM |
reponame_str |
Manancial - Repositório Digital da UFSM |
collection |
Manancial - Repositório Digital da UFSM |
repository.name.fl_str_mv |
Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM) |
repository.mail.fl_str_mv |
atendimento.sib@ufsm.br||tedebc@gmail.com |
_version_ |
1814439811024420864 |